The total Apgar score at one minute was similar in both groups.
in the digitalis group was 300 g less than that of the infants in the control group (P<0.02 using Student's t test). The individual birth weights of infants in both groups were recalculated according to the criteria of Lubchenco et al. (1963) , which takes into account differences in gestational age at birth and the sex of the infant, and also using the method recommended by Thomson et al. (1968) , which includes, in addition to Lubchenco's criteria, correction factors for the differing maternal heights and weights. The percentile weights for gestational age of the infants were compared by means of t tests and were similar in both groups of patients, suggesting that the difference in birth weight was purely reflective of the relative prematurity of the digitalis group and in no way indicated growth retardation.
The total Apgar score at one minute was similar in both groups.
Discussion Some similarity in response to cardiac glycosides of myocardium and myometrium was reported by Norris (1961) , who showed increased tone and resistance to anoxia in digitalized myometrium in vitro. He was unable to show any effect on the time of onset of labour or duration of labour when digitalis in varying doses was given to primiparous patients for the last two weeks of pregnancy. He explained this observation by suggesting that digitalis decreases the efficiency of the normal heart and by analogy implied that digitalis could be expected only to increase the efficiency of a "failing" uterus. It has since been clearly shown, however, that digitalis increases the rate of intraventricular pressure development in patients without cardiac failure (Mason and Braunwald, 1963) . We believe that the earlier onset and very much shorter labours in digitalized patients observed in this study might be consequent on the direct effect of digitalis on the myometrium exerted over a prolonged period.
Hypercholesterolaemia has been predicted as a possible complication of chenodeoxycholic acid treatment for gall stones. To exclude this, fasting serum lipids were measured in patients with stones before and at monthly intervals for six months after starting chenodeoxycholic acid. Before treatment half of a group of 36 patients with presumed cholesterol gall stones had serum cholesterol levels exceeding 260 mg/100 ml or serum triglyceride values greater than 160 mg/100 ml or both; these lipid levels were significantly greater than those in control subjects matched for age and sex. Treatment with chenode-
Introduction
Patients with cholesterol gall stones have a diminished bile acid pool (Vlahcevic et al., 1970 ) and a supersaturated bile in which there is insufficient bile acid and phospholipid to hold the cholesterol in solution (Admirand and Small, 1968) . Treatment of such patients with the bile acid chenodeoxycholic acid repletes the bile acid pool , improves cholesterol solubility in bile (Thistle and Schoenfield, 1971) , and promotes gall-stone dissolution (Bell et al., 1972; Danzinger et al., 1972) . Against the benefits of gall-stone dissolution, however, must be set any complications of bile acid therapy, including the possible side effect of induced hypercholesterolaemia (Small, 1971 (Levin and Zak, 1964) and triglyceride (Cramp and Robertson, 1968) ) showed that the mean serum cholesterol (249 ± S.E. of mean 10-8 mg/100 ml) and triglyceride (135 ± 13-4 mg/100 ml) levels were both significantly greater than the corresponding figures in the control subjects (224 ± 4.4 mg/100 ml; F = 14-17; P<0 01; and 103 ± 5-4 mg/100 ml; F = 12-81; P<0 01).
In men with gall stones the mean serum triglyceride level was considerably higher than in their age-matched controls. In women, whether grouped together or separated into two age groups, the trend to higher triglyceride levels was not statistically significant. Nevertheless, their mean serum cholesterol concentrations (255 ± 13-7 mg/100 ml) were significantly greater than those in the controls (220 ± 4.9 mg/100 ml; F = 24-18; P<0-001). This difference was also present in the under-45 age group (F = 8'15; P<0-05) but was more evident in the older women (F = 17-92; P<0 01).
In general the results of lipoprotein electrophoresis showed that patients with hypercholesterolaemia had an increased beta band while patients with hypertriglyceridaemia had an increased pre-beta band.
BODY WEIGHT IN UNTREATED PATIENTS
When men and women were considered together the gall-stone patients (mean body weight 70-8 ± 2-3 kg) were not significantly heavier than the matched control subjects (66-0 ± 1-4 kg). However, body weight was significantly greater in men (78-4 + 4 0 kg; F = 11 9; P<0 01) and in younger women (68-7 + 4.3 4-3 kg; F = 7-12; P<0 05) with gall-stones than in the corresponding control subjects, who weighed 70-6 + 1-2 kg and 61-3 ± 1-9 kg respectively. There was no significant difference between female patients aged 45-65 years (body weight 67-6 ± 3-2 kg) and their controls (67-8 ± 3-1 kg).
EFFECTS OF TREATMENT ON FASTING SERUM LIPIDS
The fasting serum lipids before and after chenodeoxycholic acid (0-5-1-5 g/day) are shown in the chart. There was no change in mean serum cholesterol levels before treatment and at monthly intervals after therapy. The pretreatment serum triglyceride levels, however, fell from 118 (± 11 7) mg/100 ml before treatment to 102 (± 10-2), 97 (± 6 6), and 95 (± 7-2) mg/100 ml after one, three, and six months respectively of bile acid feeding. The statistical significance of the difference between the results before and after treatment became greater with each successive month (t = 2-77, P<0-05 at three months; and t = 3-76, P<0 005 after six months of therapy). There was no significant change in body weight during treatment (65-0 ± 4-2 kg before and 67-6 ± 2-9 kg after treatment). Thorbjarnson, 1969) . In our series of gall-stone patients higher serum cholesterol levels were found mainly in older women, while male patients tended to show hypertriglyceridaemia, as has been suggested by Schersten et al. (1972) . The men were more often obese, this being a common feature of patients with primary hypertrnglyceridaemia. Previous epidemiological studies have shown that the risk of gall stones is about twice as great in those who are 20% above median weight for their sex-height group (Friedman et al., 1966) as in those who are 10% below this weight; careful dietary studies (Sarles et al., 1957; Sarles et al., 1969) have shown that gall-stone patients have a significantly higher calorie intake than control subjects. Obesity, however, is by no means always present in patients with gall stones (Comess et al., 1967; Sarles et al., 1969; Wheeler et al., 1970) . Other factors associated with hypertriglyceridaemia were not conspicuous in the present group of patients. Only one patient admitted to moderately heavy alcohol intake and one had diabetes mellitus which was controlled with diet and oral hypoglycaemic agents.
Discussion
It was speculated that bile acid administration might cause hypercholesterolaemia both by enhancing intestinal absorption of cholesterol and by inhibiting hepatic conversion of cholesterol to bile acids (Small, 1971) . Opposing these possible mechanisms is the depression of small-intestinal cholesterol synthesis (a major source of exchangeable cholesterol) by bile acids (Dietschy, 1968) and the fact that hepatic cholesterol accumulation would inhibit its own synthesis from acetate (Wilson, 1972) . Individual bile acids may differ in their effect on cholesterol metabolism. In rats taurocholate suppressed cholesterol 7-alphahydroxylase activity (the rate-limiting enzyme in the conversion of cholesterol to bile acids) but taurochenodeoxycholate did not (Mosbach, 1972) . We have found no change in serum cholesterol in patients given chenodeoxycholic acid, but effects on extravascular pools remain possible.
Chenodeoxycholic acid had a small but significant effect in reducing serum triglyceride concentrations. In most patients this occurred within the normal range, but it was also evident in three patients with hypertriglyceridaemia. This was not associated with change in body weight and the mechanism whereby chenodeoxycholic acid lowered serum triglyceride levels is unknown. Several lines of evidence suggest that there may be a reciprocal relation between bile acid pool size and plasma triglyceride concentrations. Before treatment patients with cholesterol gall stones have a diminished bile acid pool (Vlahcevic et al., 1970) , and in our patients the pretreatment serum triglyceride levels were high. Conversely, after bile acid feeding the serum triglyceride levels fell. There is other indirect evidence that bile acids may influence triglyceride metabolism. For example, treatment with the anion-binding resin cholestyramine depletes bile acid stores and after cholestyramine therapy there is a temporary rise in serum triglyceride levels (Jones and Dobrilovic, 1969) . Similarly, ileal resection depletes the bile acid pool (Abaurre et al., 1969; Dowling et al., 1970) , and patients with ileectomy may occasionally have hypertriglyceridaemia (Press et al., 1972) .
The effect of chenodeoxycholic acid on serum triglyceride levels could be due to either depressed synthesis or more rapid clearance. Clearance has not been studied but several investigations suggest that bile acids may affect triglyceride synthesis. Bile acids may inhibit the re-esterification of monoglycerides and fatty acids to triglycerides in rat small bowel (Dietschy, 1968; Senior, 1969) but whether they affect de novo intestinal triglyceride synthesis has yet to be established. It has also been shown that cholic acid depresses fatty acid synthesis in pigeon liver (Seitz and Brand, 1961) , but again hepatic triglyceride synthesis has not been studied.
A third possibility concerns hepatic phospholipid synthesis. Triglycerides and phospholipids share a common precursor, the diglycerides, and since bile acids increase hepatic phospholipid synthesis (Nilsson and Schersten, 1970 ) the diversion of diglyceride to this pathway could reduce the throughput to triglyceride.
Whatever the mechanism for the triglyceride-lowering effect of chenodeoxycholic acid, treatment with this bile acid not only promotes gall-stone dissolution but may also be useful as a treatment for hypertriglyceridaemia.
Introduction
Three years ago we proposed the hypothesis that growth hormone ovexproduction is a casual factor in the development of diabetic angiopathy. It is a working hypothesis based on the facts that the plasm growth hormone level is very high and fluctuates throughout life in diabetic patients and that surgical removal of the source of growth hormone production inhibits the further development of vascular changes in severe long-term diabetic angiopathy (Lundbaek et al., 1970; Hansen, 1972) .
The practical conclusion of this working hypothesis is that attempts at growth hormone suppression by pharmacological means in diabetic patients should be pursued, particularly since hypophysectomy is not an ideal procedure for many reasons. The exercise test developed in our laboratory (Hansen, 1972) [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] beats/mi lasting for less than five minutes. All the subjects were fully informed of the experimenta nature of the investigation and of the possi-ble side effects. Only patients who had had diabetes for less than five years and had normal blood pressure were investigated.
Methods and Results
The exercise test consisted in a control period, an exercise period of 450 kg/min for 40 minutes on a bicycle ergometer, and a post-exercise period. ht was done once with somatostatin and one without.
In most experiments somatostaun was given as a rapid intravenous injection (two minutes) of 250 ,ug 10 minutes before beginning exercise, followed by a continuous infusion of 250 )ug for the next 60 minutes. In four experiment-all on nondia,betics-somatostatin was given in six short injections every 10 minutes from 10 minutes before ito 40 minutes after starting exercise. The results were not apprecibly different in -these two experiments.
Plasma growth hormone was determined with a single antibody radioimunoassay employing wick-chromatography (0r,skov et al., 1968) . A Wilhelmi preparation (HS 1216 C) was used for growth hormone standards.
The average curve for the seven non-diabetics is shown in fig. 1 . Tlhe average rise was lower when somatostin was given. The suppression is statistically significant when using the paired t test at the beginning of the work period; after 20, 30, and 40 minutes of work; and 10, 50, and 60 minutes after cessation of work (2 P <005).
